Lista de obras - Gérald Raverot - Dominio Público Uruguay

18F-FDG PET/CT findings in a patient with isolated intracranial Rosai-Dorfman disease.

artículo científico publicado en 2013

A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

scientific article published on 17 October 2019

A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors

scientific article published on 01 September 2007

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.

artículo científico publicado en 2013

A prognostic clinicopathologic classification of pituitary endocrine tumors

artículo científico publicado en 2014

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

scholarly article by Jacqueline Trouillas et al published June 2018 in European Journal of Endocrinology

Aggressive prolactinomas: how to manage?

artículo científico publicado en 2020

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

artículo científico publicado en 2013

Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

artículo científico publicado en 2012

An old retrocardiac mass fortuitously reclassified as paraganglioma

scientific article published on 24 October 2016

Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up

artículo científico publicado en 2020

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

artículo científico publicado en 2007

Biological and radiological exploration and management of non-functioning pituitary adenoma.

artículo científico

Cabergoline therapy of paraneoplastic Cushing syndrome in children

artículo científico publicado en 2010

Centralization errors in comparative genomic hybridization array analysis of pituitary tumor samples.

artículo científico publicado en 2018

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis

artículo científico publicado en 2020

Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases

artículo científico publicado en 2012

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

artículo científico publicado en 2010

Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours

scientific article published on 03 April 2019

Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.

artículo científico publicado en 2010

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study

artículo científico publicado en 2019

Dramatic change in skin color after bilateral adrenalectomy in Cushing's disease

artículo científico publicado en 2016

Dysregulation of cell cycle in animal models and human neuroendocrine pituitary tumors (PitNET).

artículo científico publicado en 2018

Ectopic ACTH syndrome in children and adolescents

artículo científico publicado en 2011

Endoscopy versus microsurgery: results in a consecutive series of nonfunctioning pituitary adenomas

artículo científico publicado en 2009

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

artículo científico publicado en 2017

Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study

artículo científico publicado en 2020

Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal

article

Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth.

artículo científico publicado en 2015

Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies

scientific article published on 31 October 2013

Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features

artículo científico publicado en 2007

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

artículo científico publicado en 2017

Giant prolactinomas in women

artículo científico publicado en 2013

Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy

scientific article published on 20 April 2020

HMGA1-pseudogene expression is induced in human pituitary tumors.

artículo científico publicado en 2015

How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020

artículo científico publicado en 2020

Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients.

artículo científico publicado en 2012

Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

artículo científico publicado en 2020

Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women

artículo científico publicado en 2004

Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.

artículo científico publicado en 2011

Is Gross Total Resection Reasonable in Adults with Craniopharyngiomas with Hypothalamic Involvement?

artículo científico publicado en 2019

Ketoconazole in Cushing's disease: is it worth a try?

artículo científico publicado en 2014

Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients

artículo científico publicado en 2014

Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies

artículo científico

MicroRNAs in pituitary tumors.

artículo científico publicado en 2017

Mir-23b and miR-130b expression is downregulated in pituitary adenomas

artículo científico publicado en 2014

Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.

artículo científico publicado en 2006

New targeted therapies in pituitary carcinoma resistant to temozolomide

artículo científico publicado en 2012

Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic.

artículo científico publicado en 2013

Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development

scientific journal article

Pasireotide: A potential therapeutic alternative for resistant prolactinoma

artículo científico publicado en 2018

Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment

artículo científico publicado en 2018

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

artículo científico publicado en 2015

Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.

artículo científico publicado en 2012

Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.

artículo científico publicado en 2015

Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification

scientific article published on 01 October 2019

Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography

artículo científico publicado en 2008

Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up

artículo científico publicado en 2010

Prognostic factors of regrowth in nonfunctioning pituitary tumors

artículo científico publicado en 2017

Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach.

artículo científico publicado en 2010

Reconsidering olfactory bulb magnetic resonance patterns in Kallmann syndrome

artículo científico publicado en 2017

Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification

artículo científico publicado en 2017

Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade

artículo científico publicado en 2017

Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma

artículo científico publicado en 2008

Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability

article

Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study

scientific article published on 29 September 2018

Silent GH pituitary tumor: diagnostic and therapeutic challenges

artículo científico publicado en 2013

Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.

artículo científico publicado en 2016

Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females ⬇️

artículo científico publicado el 1 de noviembre de 2003

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

artículo científico publicado en 2016

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

artículo científico publicado en 2017

Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.

artículo científico publicado en 2010

The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications

artículo científico publicado en 2019

Therapeutic innovations in endocrine diseases - part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas.

artículo científico publicado en 2016

Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.

artículo científico publicado en 2017

Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016.

artículo científico publicado en 2018

Triple-A syndrome: a wide spectrum of adrenal dysfunction.

artículo científico publicado en 2017

Unusual neurologic presentation of aseptic abscesses syndrome.

artículo científico publicado en 2018

X-linked sex-determining region Y box 3 (SOX3) gene mutations are uncommon in men with idiopathic oligoazoospermic infertility

artículo científico publicado en 2004

Lista de obras de Gérald Raverot

18F-FDG PET/CT findings in a patient with isolated intracranial Rosai-Dorfman disease.

A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.

A prognostic clinicopathologic classification of pituitary endocrine tumors

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

Aggressive prolactinomas: how to manage?

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

An old retrocardiac mass fortuitously reclassified as paraganglioma

Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

Biological and radiological exploration and management of non-functioning pituitary adenoma.

Cabergoline therapy of paraneoplastic Cushing syndrome in children

Centralization errors in comparative genomic hybridization array analysis of pituitary tumor samples.

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis

Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study

Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours

Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study

Dramatic change in skin color after bilateral adrenalectomy in Cushing's disease

Dysregulation of cell cycle in animal models and human neuroendocrine pituitary tumors (PitNET).

Ectopic ACTH syndrome in children and adolescents

Endoscopy versus microsurgery: results in a consecutive series of nonfunctioning pituitary adenomas

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study

Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal

Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth.

Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies

Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

Giant prolactinomas in women

Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy

HMGA1-pseudogene expression is induced in human pituitary tumors.

How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020

Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients.

Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women

Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.

Is Gross Total Resection Reasonable in Adults with Craniopharyngiomas with Hypothalamic Involvement?

Ketoconazole in Cushing's disease: is it worth a try?

Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients

Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies

MicroRNAs in pituitary tumors.

Mir-23b and miR-130b expression is downregulated in pituitary adenomas

Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.

New targeted therapies in pituitary carcinoma resistant to temozolomide

Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic.

Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development

Pasireotide: A potential therapeutic alternative for resistant prolactinoma

Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.

Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.

Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification

Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography

Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up

Prognostic factors of regrowth in nonfunctioning pituitary tumors

Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach.

Reconsidering olfactory bulb magnetic resonance patterns in Kallmann syndrome

Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification

Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade

Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma

Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability

Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study

Silent GH pituitary tumor: diagnostic and therapeutic challenges

Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.

Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females ⬇️

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.

The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications

Therapeutic innovations in endocrine diseases - part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas.

Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.

Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016.

Triple-A syndrome: a wide spectrum of adrenal dysfunction.

Unusual neurologic presentation of aseptic abscesses syndrome.

X-linked sex-determining region Y box 3 (SOX3) gene mutations are uncommon in men with idiopathic oligoazoospermic infertility